TVTX
Travere Therapeutics Inc
Biopharmaceutical company focused on rare kidney and metabolic diseases
CUSIP: 89422G107HealthcareUS1 holder
Total Value
$46.63M
Total Shares
2.60M
Net Share Change
-300.0K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$46.63M2.60M shares
TRIM-300.0K(-10.3%)